Compare ULCC & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ULCC | TNDM |
|---|---|---|
| Founded | 1994 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 2021 | 2013 |
| Metric | ULCC | TNDM |
|---|---|---|
| Price | $5.36 | $18.98 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 17 |
| Target Price | $5.67 | ★ $24.35 |
| AVG Volume (30 Days) | ★ 3.7M | 1.2M |
| Earning Date | 02-11-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,724,000,000.00 | $1,007,001,000.00 |
| Revenue This Year | $18.37 | $8.59 |
| Revenue Next Year | $12.30 | $10.28 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 17.87 |
| 52 Week Low | $2.89 | $9.98 |
| 52 Week High | $9.58 | $35.12 |
| Indicator | ULCC | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 50.12 | 41.15 |
| Support Level | $4.93 | $18.34 |
| Resistance Level | $6.49 | $20.27 |
| Average True Range (ATR) | 0.50 | 1.12 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 35.47 | 23.33 |
Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers. Majority of revenue is from Domestic flight follow by International.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.